{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:42:13Z","timestamp":1763746933269},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1924,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr. Blood Cancer"],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.1002\/pbc.22611","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T05:07:35Z","timestamp":1274936855000},"page":"1217-1220","source":"Crossref","is-referenced-by-count":37,"title":["Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma"],"prefix":"10.1002","volume":"55","author":[{"given":"Alexandra","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoginder N.","family":"Vaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee M.","family":"Hilliard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,26]]},"reference":[{"key":"10.1002\/pbc.22611-BIB1|cit2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01218365","article-title":"The use of the Calvert formula to determine the optimal carboplatin dosage","volume":"121","author":"van Warmerdam","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1002\/pbc.22611-BIB2|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma. The seventh sickle cell nephropathy","volume":"19","author":"Davis","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1002\/pbc.22611-BIB3|cit4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<128::AID-CNCR18>3.0.CO;2-1","article-title":"Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumor","volume":"78","author":"Avery","year":"1996","journal-title":"Cancer"},{"key":"10.1002\/pbc.22611-BIB4|cit5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/modpathol.3800934","article-title":"Renal medullary carcinoma: Report of seven cases from Brazil","volume":"20","author":"Watanabe","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1002\/pbc.22611-BIB5|cit6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<551::AID-MPO5>3.0.CO;2-5","article-title":"Renal medullary carcinoma: Prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of bcr\/abl rearrangement","volume":"33","author":"Stahlschmidt","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1002\/pbc.22611-BIB6|cit7","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/01.ju.0000158448.56888.09","article-title":"Renal medullary carcinoma and ABL gene amplification","volume":"173","author":"Simpson","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/pbc.22611-BIB7|cit8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/cncr.20049","article-title":"Gene expression profiling of renal medullary carcinoma: Potential clinical relevance","volume":"100","author":"Yang","year":"2004","journal-title":"Cancer"},{"key":"10.1002\/pbc.22611-BIB8|cit9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.juro.2009.03.078","article-title":"Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy","volume":"82","author":"Albadine","year":"2009","journal-title":"J Urol"},{"key":"10.1002\/pbc.22611-BIB9|cit10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.2008.44","article-title":"Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior","volume":"21","author":"Cheng","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1002\/pbc.22611-BIB10|cit11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.urology.2007.06.1124","article-title":"Renal medullary carcinoma: The Bronx experience","volume":"70","author":"Hakimi","year":"2007","journal-title":"Urology"},{"key":"10.1002\/pbc.22611-BIB11|cit12","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0022-5347(05)67733-6","article-title":"Renal medullary carcinoma: Can early diagnosis lead to long-term survival?","volume":"163","author":"Selby","year":"2000","journal-title":"J Urol"},{"key":"10.1002\/pbc.22611-BIB12|cit13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.urology.2008.05.009","article-title":"High-dose-intensity MVAC for advanced renal medullary carcinoma: Report of three cases and literature review","volume":"72","author":"Rathmell","year":"2008","journal-title":"Urology"},{"key":"10.1002\/pbc.22611-BIB13|cit14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/pbc.20292","article-title":"Significant responses to platinum-based chemotherapy in renal medullary carcinoma","volume":"44","author":"Strouse","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.22611-BIB14|cit15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20780","article-title":"Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma","volume":"47","author":"Bell","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.22611-BIB15|cit16","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1200\/JCO.2005.05.0344","article-title":"Medullary renal cell carcinoma and response to therapy with bortezomib","volume":"24","author":"Ronnen","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.22611","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.22611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:28:37Z","timestamp":1625398117000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.22611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,26]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.22611","relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,26]]}}}